Evidence map›Paper›PMID 33460400›Full record

ArticleAging2020

Prognostic relevance of SMC family gene expression in human sarcoma.

Jian Zhou, Gen Wu, Zhongyi Tong, Jingjing Sun, Jing Su, Ziqin Cao, Yingquan Luo, Wanchun Wang

Open access · greenAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. SMC6 expression & outcome of breast cancer.The Indian journal of medical research · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Association ofAging · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jian ZhouDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
Gen WuDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
Zhongyi TongDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
Jingjing SunDepartment of Anesthesiology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, Zhejiang, China.
Jing SuThe Center for Medical Genetics, School of Life Science, Central South University, Changsha 410008, China.
Ziqin CaoDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
Yingquan LuoDepartment of General Medicine, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
Wanchun WangDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
Second Xiangya Hospital of Central South University · CNCentral South University · CNSecond Affiliated Hospital of Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the prognostic value of the expression of genes encoding structural maintenance of chromosomes (SMCs) in human sarcoma.

resultsWe found that the levels of SMC1A, SMC2, SMC3, SMC4, SMC5 and SMC6 mRNA were all higher in most tumors compared to normal tissues, and especially in sarcoma. According to the Cancer Cell Line Encyclopedia (CCLE), SMC1A, SMC2, SMC3, SMC4, SMC5 and SMC6 are also highly expressed in sarcoma cell lines. Results of Gene Expression Profiling Interactive Analysis (GEPIA) indicated that high expression of SMC1A was significantly related to poor overall survival (OS) (p<0.05) and disease-free survival (DFS) in sarcoma (p<0.05). Additionally, strong expression of SMC2 was significantly related to poor OS in sarcoma (p<0.05). In contrast, SMC3, SMC4, SMC5, and SMC6 expression had no significant impact on OS or DFS in sarcoma.

conclusionsExpression of SMC family members is significantly different in sarcoma relative to normal tissues, and SMC1A and SMC2 may be useful as prognostic biomarkers.

methodsWe performed a detailed comparison of cancer and normal tissues regarding the expression levels of mRNA for SMC family members in various cancers including sarcoma through ONCOMINE and GEPIA (Gene Expression Profile Interactive Analysis) databases.

Indexed as

Adenosine TriphosphatasesCell Cycle ProteinsCell Line, TumorChondroitin Sulfate ProteoglycansChromosomal Proteins, Non-HistoneDisease-Free SurvivalFibrosarcomaHistiocytoma, Malignant FibrousHumansLeiomyosarcomaLiposarcomaLiposarcoma, MyxoidPrognosisRNA, MessengerSarcomaSarcoma, SynovialAdenosine TriphosphatasesCell Cycle ProteinsChondroitin Sulfate ProteoglycansChromosomal Proteins, Non-HistoneRNA, MessengerSMC2 protein, humanSMC3 protein, humanSMC4 protein, humanSMC5 protein, humanSMC6 protein, humanStructural Maintenance of Chromosome Protein 1bioinformatics analysisexpressionprognosissarcomaSMC

Identifiers

PMID33460400
PMCPMC7835044
OpenAlexW3118205813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.